puromycin aminonucleoside has been researched along with Blood Coagulation Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chanley, MA; Kerlin, BA; Nieman, MT; Sharma, R; Smoyer, WE; Waller, AP | 1 |
| Correa-Rotter, R; Cruz, C; Juárez-Nicolás, F; Pedraza-Chaverrí, J; Tapia, E | 1 |
2 other study(ies) available for puromycin aminonucleoside and Blood Coagulation Disorders
| Article | Year |
|---|---|
Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome.
Topics: Animals; Antithrombins; Biomarkers; Blood Coagulation; Blood Coagulation Disorders; Disease Models, Animal; Doxorubicin; Elasticity; Fibrinogen; Hemostasis; Hypoalbuminemia; Male; Nephrotic Syndrome; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Serum Albumin; Severity of Illness Index; Thrombin; Thrombosis | 2015 |
Abnormalities of coagulation in experimental nephrotic syndrome.
Topics: Albuminuria; alpha-2-Antiplasmin; Animals; Antithrombin III; Blood Coagulation Disorders; Blood Coagulation Factors; Fibrinolysis; Hypercholesterolemia; Male; Nephrotic Syndrome; Partial Thromboplastin Time; Polyuria; Proteinuria; Prothrombin Time; Puromycin Aminonucleoside; Rats; Rats, Wistar | 1994 |